Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
exbivirumab (1 trial)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
End Stage Liver Disease (Phase 2)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Liver Diseases (Phase 2)
Trials (1 total)
Trial APIs (2 total)